MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
University Hospital Heidelberg
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital Heidelberg (3)
2020
-
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: A subanalysis from the RATIFY trial
Blood Advances, Vol. 4, Núm. 19, pp. 4945-4954
-
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study
Leukemia, Vol. 34, Núm. 9, pp. 2333-2341